sickle cell

News

After failure in sickle cell, Fulcrum merges with Slate

Following the failure of its sickle cell programme, Fulcrum Therapeutics will merge with Slate Medicines to advance Slate's migraine therapy.

Digital

How social media is helping clinicians on the front line in ...

Social media is unique in its capacity to gather insight into the thoughts and opinions of large numbers of healthcare professionals (HCPs) quickly.

Partner Content

Partner Content

Commercialization of novel gene-editing technology in beta-t...

Gene therapies and research into them have grown immensely in recent years, offering more novel tools in regenerative medicine to fight disease, including rare diseases and genetic disorders.

News

Novartis nets potential blockbuster approval with sickle cel...

A new drug to treat painful episodes associated with sickle cell disease from Novartis is poised to hit the US market after approval from the FDA.

News

Parliamentary probe finds racism evidence in NHS sickle cell...

Patients with sickle cell disease are facing racism in the NHS that is putting their lives a risk, claims a new report.

News

FDA accelerates review of Novartis' sickle cell drug

The FDA has accelerated its review of Novartis’ sickle cell drug crizanlizumab after the company filed phase 2 results showing its effectiveness as a treatment for life threatening and pain

After failure in sickle cell, Fulcrum merges with Slate

How social media is helping clinicians on the front line in ...

Commercialization of novel gene-editing technology in beta-t...

Novartis nets potential blockbuster approval with sickle cel...

Parliamentary probe finds racism evidence in NHS sickle cell...

FDA accelerates review of Novartis' sickle cell drug

ESC26: Isomab safety evidence on blood vessel growth for CAD

Discover a new era of healthcare panel engagement: Grounded ...

sickle cell

Editor's Picks